A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
This is not correct: Your 24-hour urine test results should show that your cortisol levels are still quite high despite any current treatments. This is correct: Your 24-hour urine test results should show that your cortisol levels are quite high. This is not correct: Initially, the medicine might be given through a drip into your arm (intravenously), and then later, it may be given as an injection under your skin (subcutaneously). This is correct: Initially, the medicine was given through a drip into the arm (intravenously), but now it is given as an injection under the skin (subcutaneously).
Överblick
Vad handlar denna studie om?
This study is investigating a new medication called Lu AG13909 for adults who have Cushing's disease. Cushing's disease is a rare but serious condition that happens when your body makes too much of a hormone called cortisol. High cortisol levels can lead to various health problems. We want to find out if Lu AG13909 can help bring these cortisol levels back into a healthy range.
There are three main things we hope to learn from this study. Firstly, we want to see how well Lu AG13909 works in reducing cortisol levels. Secondly, it's very important to understand how safe the medicine is and if people can take it without too many uncomfortable side effects. Lastly, we'll be studying how your body processes the medicine – how it's absorbed, distributed, and eventually leaves your system. This helps us understand the best way to give the medicine.
By taking part, you would be helping doctors and researchers understand more about Cushing's disease and if this new medicine could be a helpful treatment option in the future. The study is divided into several parts, so we can carefully monitor your progress and gather all the necessary information about the medicine's effects over time.
Viktiga punkter
- This study tests a new medicine (Lu AG13909) for Cushing's disease.
- It aims to lower high cortisol levels and check for safety.
- Participants will receive the medicine and have regular health checks.
- The study lasts several months, with follow-up periods.
- Suitable for adults aged 18-70 with pituitary-driven Cushing's disease.
Vem kan vara berättigad?
To join this study, you must be an adult aged between 18 and 70 years old and have a confirmed diagnosis of Cushing's disease. This means your high cortisol levels are caused by a problem with your pituitary gland, a small gland in your brain. Doctors would have confirmed this using tests like an MRI scan of your brain, or other specific blood tests.
Your 24-hour urine test results should show that your cortisol levels are still quite high despite any current treatments. While you might have other health conditions like diabetes or high blood pressure, these need to be well-managed. If you are currently taking other medicines for Cushing's disease, you might need to stop them for a short time before starting this study.
There are some reasons why you wouldn't be able to join. For example, if you are pregnant, breastfeeding, or planning to get pregnant, you cannot take part. If you have severe and uncontrolled health issues, a known allergy to the study medicine, or if your doctor believes you need surgery for your pituitary gland very soon, you would also not be able to participate. The medical team will check all these carefully to make sure the study is safe for you.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Är du mellan 18 och 70 år gammal?
- Do you have a confirmed diagnosis of Cushing's disease caused by your pituitary gland?
- Are your current 24-hour urine cortisol levels still quite high?
- Are any other health conditions you have (like diabetes) generally well-controlled?
- Are you not pregnant, breastfeeding, or planning to become pregnant?
Vad innebär deltagande?
If you join this study, you will go through different periods where you will receive the study medicine, Lu AG13909. Initially, the medicine might be given through a drip into your arm (intravenously), and then later, it may be given as an injection under your skin (subcutaneously). The dose of the medicine may be adjusted during these periods to find what works best for you. During the study, you will have regular visits to the clinic. These visits will involve various tests, such as blood tests (to check cortisol levels and overall health), urine tests, physical examinations, and heart rhythm checks (ECGs). These assessments help us monitor how you are responding to the medicine and ensure your safety.
After these initial treatment periods, there will be a longer `Maintenance Period` where you will continue to receive the medicine, followed by an `Extension Period` if you and your doctor agree. Throughout the entire study and after finishing the medicine, there will be `Safety Follow-up Periods` to check on your long-term health. The total duration of your participation could range from several months to potentially longer, depending on which parts of the study you participate in.
Potentiella risker och fördelar
Platser (27)
- University of Michigan Health-A. Alfred Taubman Health Care CenterVerifierat postnummerAnn Arbor, USA
- Washington University School of Medicine in St. LouisVerifierat postnummerSt Louis, USA
- Hospices Civils de Lyon (HCL) - Hopital Louis Pradel - Centre De Reference Maladie De Rendu-OslerVerifierat postnummerBron, Frankrike
- Centre Hospitalier Universitaire de Lille (CHU Lille)Verifierat postnummerLille, Frankrike
- Centre Hospitalier Universitaire de Bordeaux - Hopital Haut-LevequeVerifierat postnummerPessac, Frankrike
- Centre Hospitalier Universitaire d'Angers - Centre de recherche cliniqueVerifierat postnummerAngers, Frankrike
- Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital de la Conception - Pole Psychiatrie C...Verifierat postnummerMarseille, Frankrike
- AP-HP - Hôpital BicêtreVerifierat postnummerLe Kremlin-Bicêtre, Frankrike
- Aversi Clinic - TbilisiVerifierat postnummerTbilisi, Georgien
- Multiprofile Clinic - Consilium MedullaVerifierat postnummerTbilisi, Georgien
- Aversi Clinic - TbilisiVerifierat postnummerTbilisi, Georgien
- Pecsi Tudomanyegyetem (PTE) (University of Pecs)Verifierat postnummerPécs, Hungary
Vanliga frågor
What is Cushing's disease?
Cushing's disease is a condition where your body makes too much of a hormone called cortisol, often due to a small growth in your pituitary gland.
What is the new medicine being tested?
The new medicine is called Lu AG13909. It's being studied to see if it can help reduce high cortisol levels in people with Cushing's disease.
Hur kommer jag att få medicinen?
The medicine might be given through a drip (IV) into your arm initially, and then later as an injection under your skin (subcutaneously).
Hur länge kommer studien att pågå?
The study has several parts, so your total participation could last for several months, potentially longer if you join the extension period.
Will I have to stop my current medicines?
If you are taking other medicines for Cushing's disease, you might need to stop them for a short time before starting the study. Your doctor will advise you.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.